Table 1.
IC50 values of hydroxylated R-antofine analogs
Cmpd | E-ring oxygenation | IC50 (μM) | Predicted C.brain/C. blood | |||
---|---|---|---|---|---|---|
A549 | DU145 | KB | KBvin | |||
3a | 13R-OH | 2.81 ± 0.42 | 3.20 ± 0.49 | 1.83 ± 0.36 | 3.42 ± 0.38 | 0.059 |
3b | 13S-OH | 0.27 ± 0.035 | 0.85 ± 0.094 | 0.50 ± 0.077 | 0.64 ± 0.080 | 0.059 |
7 | C13-OMe, Δ12–13 | 5.97 ± 0.84 | 10.30 ± 2.02 | 12.00 ± 2.18 | 2.64 ± 0.35 | 0.044 |
8 | C12, C=O | 0.29 ± 0.051 | 0.71 ± 0.083 | 0.50 ± 0.064 | 0.43 ± 0.052 | 0.334 |
9a | 12R-OH | 0.61 ± 0.087 | 0.70 ± 0.078 | 0.78 ± 0.085 | 0.64 ± 0.081 | 0.062 |
9b | 12S-OH | 2.27 ± 0.40 | 1.80 ± 0.39 | 1.81 ± 0.23 | 2.21 ± 0.32 | 0.062 |
R-anto-fine | -- | 0.022 ± 0.007 | 0.025 ± 0.005 | 0.036 ± 0.008 | 0.025 ± 0.007 | 0.980 |